Atrial Fibrillation: An Overview on Abnormal Rapid Heart Rhythm

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
J. Marcus Wharton, MD, director of clinical cardiac electrophysiology at the Medical University of South Carolina, talks about the symptoms, causes, and consequences of atrial fibrillation.

To listen to this podcast, click here.
Related Articles
In a Phase 3 study, odanacatib significantly reduced the risk of osteoporotic fractures, but it also might have contributed to major cardiovascular events.
Approximately 6.5 million Americans are prescribed digoxin, a cardiac glycoside with a long, fascinating history.
Several new anticoagulants have entered the US market in recent years, but research to find reversal agents for these drugs is ongoing.
Digoxin increases risk of death in patients with newly diagnosed atrial fibrillation.
Latest Issues
$auto_registration$